ZMC has persistently adhered to the principle of “Quality First, Reputation Supreme”. Relying on the support of our trade partners and our own efforts, ZMC’s sales have increased steadily every year. And in fourteen consecutive years, it has been listed in the Catalogue of China’s Top 500 Import & Export Companies. In 2009, its business volume reached 415.23 million US dollars, ranking first in the line of medicines and health products in China.
Year Established: 1984
Main Competitive Advantages:
Business Type: Trading Company
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
Human Immunoglobulin (pH4) for Intravenous Injection
Dimethyl sulfoxide
Tetrahydrofuran
AMPICILLIN SODIUM FOR INJECTION